Mohan Pankaj (CIK 0001664386)

Latest company ownership

OTLK - Outlook Therapeutics, Inc.

Role: Director

Shares held

619,114

Last filed at

Jan 17, 2019

Confidence Score

50.0

2025Q4

Confidence Score History

2017Q4 2025Q4

Role: CEO

Shares held

3,046

Last filed at

Oct 27, 2023

Confidence Score

50.0

2025Q4

Confidence Score History

2020Q2 2025Q4

Exec date	Filing date	Company	Role	Signal	Confidence	Shares	% of shares	Under plan?	Amount (USD)
May 15, 2023	May 15, 2023	Sonnet BioTherapeutics Holdings, Inc.	CEO	Buy	95.0	+371,600	149.37%	✗	$82.9K
Mar 15, 2023	Mar 16, 2023	Sonnet BioTherapeutics Holdings, Inc.	CEO	Buy	91.3	+60,000	31.78%	✗	$35.1K
Jun 9, 2021	Jun 9, 2021	Sonnet BioTherapeutics Holdings, Inc.	CEO	Buy	83.8	+32,000	2.54%	✗	$49.6K
Jun 10, 2020	Jun 12, 2020	Sonnet BioTherapeutics Holdings, Inc.	CEO	Buy	60.0	+2,400	0.26%	✗	$9.8K
Jan 15, 2019	Jan 17, 2019	Outlook Therapeutics, Inc.	Director	Buy	55.0	+8,000	0.10%	✗	$5.4K
Jan 3, 2018	Jan 5, 2018	Outlook Therapeutics, Inc.	CEO	Sell	42.5	-114,677	-1.47%	✗	$134.1K
Dec 18, 2017	Dec 20, 2017	Outlook Therapeutics, Inc.	CEO	Sell	42.5	-104,131	-1.32%	✗	$119.3K